Author Question: A nurse researcher is investigating the effectiveness of a new, school-based smoking prevention ... (Read 85 times)

Jkov05

  • Hero Member
  • *****
  • Posts: 556
A nurse researcher is investigating the effectiveness of a new, school-based smoking prevention program. Which of the following should the nurse consider as a potential confounding historical factor?
 
  A) Students' existing attitudes toward tobacco use
  B) The relationship between tobacco use and alcohol use
  C) Students' respiratory health status at the commencement of the program
  D) Antismoking messages already present in the media

Question 2

A nurse has approached the unit educator with a recently-published article that calls into question the unit's practices around routine changing of peripheral intravenous sites.
 
  How should the findings of this article be best translated into practice?
  A) Unit practices should be amended to reflect the findings of the study.
  B) The nurses on the unit should combine the study results with their own expertise to create a new guide for practice.
  C) The nurses should search for further evidence before changing unit practices.
  D) The nurses should conduct a trial similar to that in the published study.



josephsuarez

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library